← Leaderboards
Clavia Ruth Wooton-Kee
Baylor College Of Medicine
$2,082,021
Attributed
$2,082,021
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $321.8K · FY2010–25$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,082,021 · 3
By mechanism
R01$1,270,443 · 1
K01$746,280 · 1
F32$65,298 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Sameer Anil Sheth$16,359,401
- Michael Lieberman$4,000,161
- Pyong Woo Park$19,694,248
- Gregory Guthrie$981,815
Others in their field
Top investigators on “Signal Pathway”
- David Heimbrook · Leidos Biomedical Research, Inc.$191,912,844
- Asrar B. Malik · University Of Illinois At Chicago$75,811,832
- Robert H Tukey · University Of California San Diego$50,504,865
- Meenhard Herlyn · University Of Pennsylvania$50,308,097
- Ian A Wilson · Scripps Research Institute, The$50,300,809
- Richard D Smith · Battelle Pacific Northwest Laboratories$46,192,560
Research focus
Signal PathwayCholestasisPathologyResponseMolecularZincLiverNuclear ReceptorsLiver FailureRegulationHepatolenticular DegenerationLiver TransplantationSymptomsMetabolicCirrhosisHepaticCopperMrna ExpressionLiver DysfunctionLiver DiseasesAtp PhosphohydrolaseGene ExpressionChip-SeqMetabolism
Grant awards (11)
Nuclear Receptor Dysfunction Reprograms Metabolism and Cellular Proliferation in Wilson's Disease$321,831
R01 · FY2025 · DK · contact PI
Nuclear Receptor Dysfunction Reprograms Metabolism and Cellular Proliferation in Wilson's Disease$305,576
R01 · FY2024 · DK · contact PI
Nuclear Receptor Dysfunction Reprograms Metabolism and Cellular Proliferation in Wilson's Disease$321,579
R01 · FY2023 · DK · contact PI
Nuclear Receptor Dysfunction Reprograms Metabolism and Cellular Proliferation in Wilson's Disease$321,457
R01 · FY2022 · DK · contact PI
Nuclear Receptors as Novel Therapeutic Targets for Wilsonâs Disease$148,956
K01 · FY2021 · DK · contact PI
Nuclear Receptors as Novel Therapeutic Targets for Wilsonâs Disease$148,956
K01 · FY2020 · DK · contact PI
Nuclear Receptors as Novel Therapeutic Targets for Wilsonâs Disease$148,956
K01 · FY2019 · DK · contact PI
Nuclear Receptors as Novel Therapeutic Targets for Wilsonâs Disease$148,956
K01 · FY2018 · DK · contact PI
Nuclear Receptors as Novel Therapeutic Targets for Wilsonâs Disease$150,456
K01 · FY2017 · DK · contact PI
Excessive Copper Levels Disrupt Hepatic Nuclear Receptor Function$17,692
F32 · FY2011 · DK · contact PI
Excessive Copper Levels Disrupt Hepatic Nuclear Receptor Function$47,606
F32 · FY2010 · DK · contact PI